We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioFocus Announces Agreement with ChanTest

News   Feb 07, 2013

 
BioFocus Announces Agreement with ChanTest
 
 
Advertisement
 

RELATED ARTICLES

A Look at How Psychedelics Bind to Serotonin Receptors

News

For the first time, scientists have solved the high-resolution structure of psychedelic compounds when they are actively bound to the 5-HT2A serotonin receptor on the surface of brain cells.

READ MORE

Team Discovers Potential Drug Targets for Aggressive Form of Pancreatic Cancer

News

Researchers have identified, in preclinical models, therapeutic targets for an extremely fast-moving and deadly form of pancreatic cancer, adenosquamous cancer of the pancreas (ASCP).

READ MORE

Collaborations Aim to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE